Literature DB >> 12670505

Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.

Kyoko Ohno-Matsui1, Takeshi Yoshida, Tomoko Uetama, Manabu Mochizuki, Ikuo Morita.   

Abstract

We previously demonstrated that differentiated retinal pigment epithelial (RPE) cells express high levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF), and a critical balance between VEGF and PEDF is important to prevent the development of choroidal neovascularization. We report here that VEGF secreted by RPE cells upregulates PEDF expression via VEGFR-1 in an autocrine manner. PEDF mRNA and protein expression was downregulated by neutralizing antibody against VEGF in differentiated human RPE cells. VEGFR-1 neutralization decreased PEDF mRNA and protein expression whereas anti-VEGFR-2 antibody had no effect. Addition of placenta growth factor (PlGF) restored PEDF expression in the presence of anti-VEGF antibody. These results demonstrate a regulatory interaction between angiogenesis stimulators and inhibitors to maintain homeostasis in normal human retina.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670505     DOI: 10.1016/s0006-291x(03)00446-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.

Authors:  M S Spitzer; B Wallenfels-Thilo; A Sierra; E Yoeruek; S Peters; S Henke-Fahle; K U Bartz-Schmidt; P Szurman
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

Review 2.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

3.  VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells.

Authors:  B Zhao; A Ma; J Cai; M Boulton
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

4.  Inhibition of choroidal neovascularization by lentivirus-mediated PEDF gene transfer in rats.

Authors:  Ya-Jie Yu; Bin Mo; Lu Liu; Yan-Kun Yue; Chang-Li Yue; Wu Liu
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

5.  Influence of vitreous factors after vitrectomy for macular edema in patients with central retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Shuichiro Eguchi; Katsunori Shimada
Journal:  Int Ophthalmol       Date:  2011-11-22       Impact factor: 2.031

Review 6.  Role of growth factors and the wound healing response in age-related macular degeneration.

Authors:  Reinier O Schlingemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

Review 7.  The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.

Authors:  Torsten Falk; Robert T Gonzalez; Scott J Sherman
Journal:  Int J Mol Sci       Date:  2010-08-05       Impact factor: 5.923

8.  Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization.

Authors:  Lazaros Konstantinidis; Irmela Mantel; Jean-Antoine C Pournaras; Leonidas Zografos; Aude Ambresin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-29       Impact factor: 3.117

9.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy.

Authors:  M Matsuoka; N Ogata; T Otsuji; T Nishimura; K Takahashi; M Matsumura
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

10.  Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium.

Authors:  Gottfried Martin; Günther Schlunck; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-14       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.